Distribution to erythrocytes of Methylphenidate [Bioanalytics]

posted by EKY – Thailand, 2019-01-04 03:08 (694 d 02:41 ago) – Posting: # 19727
Views: 1,569

According to available data that methylphenidate and its metabolites are distributed between plasma (57%) and erythrocytes (43%) in blood.

In the bioanalysis for quantification of methylphenidate in plasma, there are some hemolysis samples.

Has anyone experienced that hemolysis samples (plasma) affect the bioanalysis or the reported plasma concentrations?

Can the respective plasma concentrations from hemolysis samples be fallacious?

Best Regards,

Complete thread:

 Admin contact
21,215 posts in 4,427 threads, 1,482 registered users;
online 10 (0 registered, 10 guests [including 10 identified bots]).
Forum time: Saturday 05:49 CET (Europe/Vienna)

Science may be described as the art of systematic over-simplification –
the art of discerning what we may with advantage omit.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz